Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: I was wondering ...BaNos
3
Mar 03, 2008 12:41PM
For the sake of discussion, the stragety of an RS would be different from a 2/1 as opposed to a 10/1 (for example). The larger holders could still do business as usual on a 2/1 IMO (where smaller holders would be further stifled) where a 10/1 would have a marketly different effect on the larger holders......The numbers are subjective and extreme that I'm presenting but the idea is in an RS scenario, that all holders are impacted more equally across the board in relation to their holdings and stragety IMO.......Further, what would be more of a SP impact, a 2/1 going to .80 (where Swartz could still pummel it down to .40) or a 10/1 going to $4.00 with say Swartz going from 24 million to 2.4 million, an outstanding going from 400 million to 200 million in a 2/1 or an outstanding going from 400 million to 40 million in a 10/1?.....Just random thoughts to throw out......
2
Mar 03, 2008 06:08PM

Mar 03, 2008 07:04PM
1
Mar 03, 2008 08:13PM

Mar 04, 2008 03:13AM

Mar 04, 2008 10:26AM

Mar 04, 2008 11:14AM
1
Mar 04, 2008 11:21AM
Share
New Message
Please login to post a reply